Sign in

CIK 0001022079

  • Large accelerated filer

QUEST DIAGNOSTICS INC

Sign in to watch
Ticker
DGX
Exchange
NYSE
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
161387862
Phone
+1 973-520-2700
Business address
500 PLAZA DRIVE, SECAUCUS, NJ, 07094
Former names
CORNING CLINICAL LABORATORIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,794,069
in 6 filings, $19.8M under 10b5-1 plans

Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-23 EGLINTON MANNER CARRIE SVP, Advanced Diagnostics Shares withheld for taxes −1,368 $130.09 $178K 28,882
2022-02-23 EGLINTON MANNER CARRIE SVP, Advanced Diagnostics Shares withheld for taxes −609 $130.23 $79K 28,431
2022-01-03 RING TIMOTHY M Director Grant or award · Phantom Stock Units +247 $167.70 $41K 11,631.4
2021-11-29 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Exercise or conversion +37,565 $95.80 $3.6M 106,294
2021-11-29 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Sale −300 $153.38 $46K 105,994
2021-11-29 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Sale −3,250 $154.79 $503K 102,744
2021-11-29 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Sale −3,532 $155.77 $550K 99,212
2021-11-29 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Sale −15,908 $156.86 $2.5M 83,304
2021-11-29 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Sale −14,575 $157.53 $2.3M 68,729
2021-11-29 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Exercise or conversion · Non-Qualifed Stock Option (right to buy) −37,565 $95.80 $3.6M 0
2021-10-01 RING TIMOTHY M Director Grant or award · Phantom Stock Units +288 $143.77 $41K 11,336.62
2021-08-16 Doi Tracey Director Grant or award +905 905
2021-07-29 RUSCKOWSKI STEPHEN H Chairman, CEO and President Exercise or conversion +5,300 $95.80 $508K 289,727
2021-07-29 RUSCKOWSKI STEPHEN H Chairman, CEO and President Sale −5,300 $140.59 $745K 284,427
2021-07-29 RUSCKOWSKI STEPHEN H Chairman, CEO and President Exercise or conversion +4,193 $95.80 $402K 288,620
2021-07-29 RUSCKOWSKI STEPHEN H Chairman, CEO and President Sale −4,193 $141.22 $592K 284,427
2021-07-29 RUSCKOWSKI STEPHEN H Chairman, CEO and President Exercise or conversion · Non-Qualifed Stock Option (right to buy) −5,300 $95.80 $508K 4,193
2021-07-29 RUSCKOWSKI STEPHEN H Chairman, CEO and President Exercise or conversion · Non-Qualifed Stock Option (right to buy) −4,193 $95.80 $402K 0
2021-07-28 RUSCKOWSKI STEPHEN H Chairman, CEO and President Exercise or conversion +139,751 $95.80 $13.4M 424,178
2021-07-28 RUSCKOWSKI STEPHEN H Chairman, CEO and President Sale −139,751 $140.14 $19.6M 284,427

Page 34 of 42 · 826 trades